/SNWV
SNWV Stock - SANUWAVE Health, Inc.
Healthcare|Medical - DevicesNASDAQ
$32.25-1.77%
$0.58 (-1.77%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.48
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.67
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+64.3%upside
Target: $52.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SNWV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$31.93 – $32.57
TARGET (TP)$53.00
STOP LOSS$29.67
RISK/REWARD1:8.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.32
52W High$46.59
52W Low$20.50
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $32.63M | $20.40M | $16.74M | $13.01M | $4.06M |
| Gross Profit | $24.55M | $14.36M | $12.41M | $8.02M | $2.90M |
| Gross Margin | 75.2% | 70.4% | 74.1% | 61.7% | 71.4% |
| Operating Income | $5.42M | $-540,000 | $-8,952,000 | $-14,142,000 | $-25,200,000 |
| Net Income | $-31,372,000 | $-25,807,000 | $-10,293,000 | $-27,259,000 | $-30,937,000 |
| Net Margin | -96.1% | -126.5% | -61.5% | -209.5% | -762.6% |
| EPS | $-7.03 | $-12.19 | $-7.02 | $-19.72 | $-30.68 |
Company Overview
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
2 Bullish0 Neutral/Bearish
Price Targets
$52
Average Target
↑ 61.2% Upside
Now
$49
Low
$52
Average
$55
High
Based on 2 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 3rd 2025 | Northland Capital | Initiation | Outperform | $55 |
| July 29th 2025 | Roth Capital | Initiation | Buy | $49 |
Earnings History & Surprises
SNWVBeat Rate
100%
Last 4 quarters
Avg Surprise
+9958.7%
EPS vs Estimate
Beats / Misses
4/0
Last 12 quarters
Latest EPS
$0.46
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
+111.1%
$0.01vs$-0.09
Q4 25
+43.8%
$0.46vs$0.32
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 7, 2026 | — | — | — | — |
Q1 2026 | Mar 19, 2026 | $0.17 | — | — | — |
Q4 2025 | Nov 7, 2025 | $0.32 | $0.46 | +43.8% | ✓ BEAT |
Q3 2025 | Aug 8, 2025 | $-0.09 | $0.01 | +111.1% | ✓ BEAT |
Q2 2025 | May 9, 2025 | — | $-0.66 | — | — |
Q1 2025 | Mar 20, 2025 | — | $-1.21 | — | — |
Q4 2024 | Nov 7, 2024 | — | $-6.49 | — | — |
Q3 2024 | Aug 12, 2024 | — | $3.70 | — | — |
Q2 2024 | May 9, 2024 | — | $-1.46 | — | — |
Q1 2024 | Mar 21, 2024 | — | $11.11 | — | — |
Q4 2023 | Nov 9, 2023 | — | $-3.70 | — | — |
Q3 2023 | Aug 11, 2023 | — | $-3.70 | — | — |
Q2 2023 | May 12, 2023 | — | $-7.41 | — | — |
Q2 2023 | Apr 3, 2023 | — | $-3.70 | — | — |
Q4 2022 | Nov 14, 2022 | $-0.01 | $0.68 | +6880.0% | ✓ BEAT |
Q3 2022 | Aug 15, 2022 | $-0.01 | $3.27 | +32800.0% | ✓ BEAT |
Q2 2022 | May 26, 2022 | — | $-4.96 | — | — |
Q2 2022 | May 13, 2022 | — | $-8.67 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-3.08 | — | — |
Q1 2022 | Jan 14, 2022 | — | $-6.23 | — | — |
Latest News
Sanuwave Health Added Its UltraMIST Product Line To Healogics Isupply. With This Expansion, UltraMIST Becomes An Option For Group Purchasing Organization Members
📈 PositiveBenzinga•Dec 8, 2025, 11:02 AM
SANUWAVE Health shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositiveBenzinga•Nov 7, 2025, 04:16 PM
SANUWAVE Health Q3 EPS $0.46 Beats $0.32 Estimate, Sales $11.451M Beat $11.430M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 09:58 PM
Sanuwave Health Said Centers For Medicare & Medicaid Services' 2026 Rates For Physician Offices, Home Visits, Long-term Care, And Hospitals Are In Line With The Proposed Rule And Remain Materially Unchanged From 2025
➖ NeutralBenzinga•Nov 3, 2025, 10:05 AM
SANUWAVE Health shares are trading lower after the company issued preliminary Q3 revenue results below estimates. Also, the company cut its FY25 revenue guidance.
📉 NegativeBenzinga•Oct 7, 2025, 03:31 PM
SANUWAVE Health shares are trading lower after the company issued preliminary Q3 revenue results below estimates. Also, the company cut its FY25 revenue guidance.
📉 NegativeBenzinga•Oct 6, 2025, 08:25 PM
SANUWAVE Health Cuts FY25 Revenue Guidance From $48M-$50M To $44M-$46M
📉 NegativeBenzinga•Oct 6, 2025, 08:24 PM
Sanuwave Health Reports Prelim. Q3 Revenue $11.4M-$11.6M Down From Prior Estimates Of $12M-$12.7M
📉 NegativeBenzinga•Oct 6, 2025, 08:23 PM
Sanuwave Secures J.P. Morgan Credit Facility: $23M 4-Year Term Loan, $5M 2-Year A/R Revolver At SOFR +350 Bps; $1M Drawn, $24M Outstanding
📈 PositiveBenzinga•Sep 26, 2025, 11:08 AM
Northland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55
📈 PositiveBenzinga•Sep 3, 2025, 06:13 PM
Sanuwave Health rises after $5M payment related to patent sale
📈 PositiveSeeking Alpha•Aug 22, 2025, 07:11 PM
Roth Capital Maintains Buy on SANUWAVE Health, Raises Price Target to $55
📈 PositiveBenzinga•Aug 22, 2025, 05:19 PM
Frequently Asked Questions about SNWV
What is SNWV's current stock price?
SANUWAVE Health, Inc. (SNWV) is currently trading at $32.25 per share. The stock has moved -1.77% today.
What is the analyst price target for SNWV?
The average analyst price target for SNWV is $53.00, based on 1 analyst.
What sector is SANUWAVE Health, Inc. in?
SANUWAVE Health, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is SNWV's market cap?
SANUWAVE Health, Inc. has a market capitalization of $0.28 billion, making it a small-cap company.
Does SNWV pay dividends?
No, SANUWAVE Health, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorFHTX
Foghorn Therapeutics Inc.
$5.24
Mkt Cap: $0.3B
HSDT
Solana Company
$2.98
Mkt Cap: $0.1B
IMRX
Immuneering Corporation
$5.65
Mkt Cap: $0.2B
INGN
Inogen, Inc.
$6.71
Mkt Cap: $0.2B
MASS
908 Devices Inc.
$5.84
Mkt Cap: $0.2B
NNOX
Nano-X Imaging Ltd.
$2.99
Mkt Cap: $0.2B
OM
Outset Medical, Inc.
$3.70
Mkt Cap: $0.1B
QTRX
Quanterix Corporation
$6.59
Mkt Cap: $0.3B
SENS
Senseonics Holdings, Inc.
$6.15
Mkt Cap: $0.3B
SGHT
Sight Sciences, Inc.
$8.45
Mkt Cap: $0.4B
Explore stocks similar to SNWV for comparison